Two cases of non-functional gonadotroph adenoma: Pituitary apoplexy following a GnRH-agonist treatment revealing gonadotroph adenoma and pseudopituitary apoplexy after GnRH administration;Deux cas de macroadénomes gonadotropes silencieux: Apoplexie hypophysaire au décours d'une première injection d'agoniste de la LH-RH révélant un adénome gonadotrope pseudoapoplexie hypophysaire d'un adénome gonadotrope au décours d'un test de stimulation

Annales d'Endocrinologie

Volumn 64, Issue 3, 2003, Pages 227-231

  Hernandez Morin, N ^a   Huet, D ^a   Hautecouverture, M ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

Gn RH administration; Gn RH agonist; Gonadotroph adenoma; Immunohistochimical study; Pituitary apoplexy; Pituitary insufficiency

Indexed keywords

ALFUZOSIN; BICALUTAMIDE; CORTICOSTEROID; DESMOPRESSIN; GADOLINIUM; GONADORELIN AGONIST; LEUPRORELIN; LEVOTHYROXINE; METHYLPREDNISOLONE; RECOMBINANT FOLLITROPIN; ZOLPIDEM TARTRATE;

AGED; ARTICLE; CASE REPORT; CAVERNOUS SINUS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIABETES INSIPIDUS; DIAGNOSTIC IMAGING; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS APOPLEXY; HYPOPITUITARISM; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATE CANCER; SYMPTOM; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VOMITING;

ADENOMA; AGED; AGED, 80 AND OVER; FOLLICLE STIMULATING HORMONE; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; LUTEINIZING HORMONE; MALE; PITUITARY APOPLEXY; PITUITARY NEOPLASMS; PROSTATIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037696063     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Snyder PJ. Clinically nonfunctioning pituitary adenomas. Endocrinol Metab Clin North Am; 22: 163-175.
2. Snyder PJ. Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985; 6: 552-63.
3. Trouillas J, Girod C, Loras B, Sassolas G, Claustart B, Perrin. La cellule gonadotrope humaine normale et pathologique. Ann Endocrinol 1990; 51: 54-64.
4. Black PM, Hsu DW, Klibanski A. Hormone production in clinically non functioning pituitary adenomas. J Neurosurg 1987; 66: 244-50.
5. Comtois R, Beauregard H, Somma M, Serri O, Aris-Jilwan N, Hardy J. The clinical and endocrine outcome to transphenoidal microsurgery of non secreting pituitary adenomas. Cancer 1991; 68: 860-6.
6. Croue A, Beldent V, Rousselet MC. Contribution of immunohistochemistry, electron microscopy and cell culture to the characterization of non-functioning pituitary adenomas: a study of 40 cases. Hum Pathol 1992; 23: 1332-9.
7. Trouillas J, Girod C. Adénomes hypophysaires: histologie et cytologie. Encycl Med Chir (Endocrinologie-Nutrition). Vol. 10-023-A10. Paris: Ed. Techniques, 1994: 14.
8. Klibanski A, Jameson JL, Biller BMK. Gonadotropin and alpha-subunit responses to chronic gonadotropin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumors. J Clin Endocrinol Metab 1989; 68: 81-6.
9. Chanson P, Lahlou N, Warnet A. responses to gonadotropin releasing hormone agonist and antagonist administration in patients with gonadotroph cell adenomas. J Endocrinol Invest 1994; 17: 91-8.
10. Nobels FR, Kwekkeboom DJ, Coopmans W. A comparison between the diagnostic value of gonadotropins, alpha subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha subunit-secreting, and gonadotroph pituitary adenoma. J Clin Endocrinol Metab 1993; 77: 784-9.
11. Chanson P, Pantel J, Young J, Couzinet B, Bidart JM, Schaison G. Free luteinizing-hormone beta-subunit in normal subjects and patients with pituitary adenomas. J Clin Endocrinol Metab 1997; 82: 1397-402.
12. Chanson P, Schaison G. Pituitary apoplexy caused by Gn-RH agonist treatment revealing gonadotroph adenoma. J Clin Endocrinol Metab 1995; 80: 2267-8.
13. Greenman Y, Tordjman K, Kisch E, Razon N, Ouaknine G, Stern N. relative sparing of anterior pituitary function in patients withgrowth hormone-secreting macroadenomas: comparison with nonfunctioning macroadenomas. J Clin Endocrinol Metab 1995; 80: 1577-83.
14. Boute D, Dewailly D, Lemaire C, Christiaens JL, Mazzuca M, Fossati P. Effect of long acting GnRH agonist on clinically non-functioning pituitary adenomas. J Endocrinol Invest 1991; 14 (suppl): 45.
15. Biousse V, Newman NJ, Oyesiku, NM. Precipitating factors in pituitary apoplexy. J Neurol Neurosurg Psychiatry. 2001 Oct; 71(4): 542-5.
16. Kwekkeboom DJ, de Jong FH, Lamberts SWJ. Gonadotropin release by clinically non functioning and gonadotroph pituitaryu adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. J clin Endocrinol Metab 1989; 68: 1128-35.
17. Oppenheim DS, Kana AR, Sangha JS, Klibanski A. Prevalence of alpha-subunit hypersecretion in patients with pituitary tumors: clinically nonfunctioning and somatotroph adenomas. J Clin Endocrinol Metab 1990; 70: 859-64.
18. Daneshdoost L, Gennarelli TA, bashey HM. Identification of gonadotroph adenomas in men with clinically non-functioning adenomas by the luteinizing hormone beta-subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993; 77: 1352-5.